Overview
Isolated aniridia is a rare congenital eye disorder characterized by the complete or partial absence of the iris, the colored ring-shaped structure that controls the amount of light entering the eye. Unlike syndromic forms of aniridia (such as WAGR syndrome, which involves Wilms tumor, aniridia, genitourinary anomalies, and intellectual disability), isolated aniridia affects only the eyes and is not associated with systemic abnormalities. The condition is also known as congenital aniridia or hereditary aniridia. It is primarily caused by heterozygous loss-of-function mutations in the PAX6 gene located on chromosome 11p13, which plays a critical role in eye development. Although the hallmark feature is iris hypoplasia or absence, isolated aniridia is a panocular disorder affecting multiple structures of the eye. Patients commonly experience reduced visual acuity, photophobia (light sensitivity), and nystagmus (involuntary eye movements). Progressive complications frequently develop over time, including cataracts, glaucoma, corneal opacification (aniridia-associated keratopathy due to limbal stem cell deficiency), foveal hypoplasia, and optic nerve hypoplasia. These secondary complications can lead to significant visual impairment or blindness if not managed appropriately. There is currently no cure for isolated aniridia, and management focuses on monitoring and treating complications as they arise. Regular ophthalmologic examinations are essential throughout life. Glaucoma may be managed with topical medications or surgical intervention. Cataracts can be surgically removed, though outcomes may be complicated by other ocular abnormalities. Corneal surface disease may be addressed with lubricants, autologous serum drops, or limbal stem cell transplantation in advanced cases. Artificial iris implants and tinted contact lenses can help manage photophobia and improve cosmetic appearance. Genetic counseling is recommended for affected families, and importantly, patients with apparently isolated aniridia—particularly sporadic cases—should be evaluated to rule out deletions extending to the adjacent WT1 gene, which would indicate risk for Wilms tumor (WAGR syndrome).
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Isolated aniridia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Isolated aniridia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Isolated aniridia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Isolated aniridia.
Community
No community posts yet. Be the first to share your experience with Isolated aniridia.
Start the conversation →Latest news about Isolated aniridia
No recent news articles for Isolated aniridia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Isolated aniridia
What is Isolated aniridia?
Isolated aniridia is a rare congenital eye disorder characterized by the complete or partial absence of the iris, the colored ring-shaped structure that controls the amount of light entering the eye. Unlike syndromic forms of aniridia (such as WAGR syndrome, which involves Wilms tumor, aniridia, genitourinary anomalies, and intellectual disability), isolated aniridia affects only the eyes and is not associated with systemic abnormalities. The condition is also known as congenital aniridia or hereditary aniridia. It is primarily caused by heterozygous loss-of-function mutations in the PAX6 gene
How is Isolated aniridia inherited?
Isolated aniridia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Isolated aniridia typically begin?
Typical onset of Isolated aniridia is neonatal. Age of onset can vary across affected individuals.